Merck Serono announces collaboration in basic and clinical research in multiple sclerosis
Merck Serono, a division of Merck KGaA, Darmstadt, Germany , today announced a strategic collaboration with US ranked Brigham and Women's Hospital in Boston , to advance basic and clinical research in multiple sclerosis, with the goal of generating new and innovative discoveries that advance treatment for people living with this condition.
It is being reported that scientists have used stem cells to reverse the symptoms associated with multiple sclerosis.